This University of Helsinki coordinated project integrates immuno-oncology (IO) activities at the Universities of Helsinki and Turku, 3 University hospitals and one central hospital, 8 Finnish small or medium enterprises, several cancer patient organizations and the 9 largest IO-investing pharmaceutical companies. With a total funding of 10 million euros, Cancer IO is a significant IO focused Nordic research and innovation program.
Read the press release on the University of Helsinki website
Cancer IO – New cancer immunotherapy collaboration project comes to life!
Source: University of Helsinki, 11 May 2020